Head and Neck Squamous Cell Cancer

• CLINICAL_TRIALS trial_result · 2023-06-02
  Clinical Trial Update: To Evaluate the Efficacy and Safety of SCB01A in Subjects With r/m Squamous Cell Head and Neck Cancer [Phase 2]

  Phase 2 trial of SCB01A in recurrent/metastatic squamous cell carcinoma of the head and neck was terminated; results posted in 2023.

• CLINICAL_TRIALS trial_result · 2020-10-09
  Clinical Trial Update: Induction Chemo Then Concurrent Chemoradiotherapy With Cetuximab in Locally Advanced Head and Neck Squamous Cell Cancer [Phase 2]

  Phase 2 trial investigating induction chemotherapy followed by concurrent chemoradiotherapy with cetuximab in locally advanced head and neck…

• CLINICAL_TRIALS trial_result · 2015-11-20
  Clinical Trial Update: Cetuximab at Either 500 or 750 mg/m2 Every Other Week for Recurrent or Metastatic Head and Neck Squamous Cell Cancer [Phase 2]

  Phase 2 trial evaluating cetuximab given every other week at 500 or 750 mg/m2 in recurrent or metastatic head and neck squamous cell cancer;…